The full speaking faculty for the 6th Annual Drug Repositioning Conference has not yet been announced. Please check back in the coming weeks and months for additional information. If you'd like to download a brochure, please CLICK HERE.
Ronald Alfa, MD, Ph.D., Vice President, Discovery and Product, Recursion Pharmaceuticals
Bobbie Ann Austin, Ph.D., Program Officer, Drug Development Partnership Programs, National Center for Advancing Translational Sciences (NCATS), Office of the Director, National Institutes of Health
Paul Bogdan, Ph.D., Assistant Professor, Department of Electrical Engineering, University of Southern California
Pieter Dylst, Senior Manager Market Access and Value Added Medicines, Medicines for Europe
Rodolphe Hajj, Ph.D., Chief Pharmacology Officer, PharNext SA
Laura Kleiman, Ph.D., Executive Director, Cures Within Reach for Cancer
Daphna Laifenfeld, Ph.D., Sr. Director, Personalized & Predictive Medicine, Teva Pharmaceutical Industries
Kevin Pan, Ph.D., Chief Executive Officer, Asieris Pharmaceuticals
Xavier Paoli, CCO and VP of R&D Operations, PharNext SA
Aris Persidis, Ph.D., President, Biovista
Michael Pollastri, Ph.D., Associate Professor & Chair, Northeastern University, College of Science
Vidula Sukhatme, Founder and CEO, Global Cures